Rezolute (RZLT) Change in Accured Expenses (2012 - 2026)
Rezolute (RZLT) posted Change in Accured Expenses of -$1.4 million for Q1 2026, down 2.23% sequentially from -$1.4 million in Q4 2025, and up 60.66% YoY from -$883232.6 in Q1 2025.
Rezolute (RZLT) Change in Accured Expenses (2012 - 2026) Analysis & Trends
Rezolute has reported Change in Accured Expenses for 15 years, with the latest figure at -$1.4 million in Q1 2026.
- Quarterly Change in Accured Expenses rose 60.66% year-over-year to -$1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$238000.0 (down 158.7% YoY) and the FY2025 annual result came in at $721000.0, down 66.4% from the prior year.
- Change in Accured Expenses retreated to -$1.4 million in Q1 2026 per RZLT's latest filing, from -$1.4 million in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $2.7 million in Q3 2023 and troughed at -$3.6 million in Q1 2025.
- A 5-year average of $3058.8 and a median of -$42000.0 in 2022 frame the typical range for Change in Accured Expenses.
- The sharpest annual moves came in 2022 and 2023: Change in Accured Expenses plunged 275.0% in 2022, then soared 6550.0% in 2023.
- Over 5 years, Change in Accured Expenses stood at $2.1 million in 2022, then slumped by 125.74% to -$540000.0 in 2023, then jumped by 373.7% to $1.5 million in 2024, then plunged by 193.91% to -$1.4 million in 2025, then dropped by 2.23% to -$1.4 million in 2026.
- According to Business Quant data, Change in Accured Expenses over the past three periods registered -$1.4 million, -$1.4 million, and $667000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 222.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 492.70 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 55.78 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 212.44 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 61.62 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 68.82 Mn |
| 10 | Rezolute | 442.94 Mn | 442.94 Mn | - | -1.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.42 Mn |
| Mar 31, 2026 | -1.42 Mn |
| Dec 31, 2025 | -1.39 Mn |
| Dec 31, 2025 | -1.39 Mn |
| Sep 30, 2025 | 667,000.00 |
| Sep 30, 2025 | 667,000.00 |
| Jun 30, 2025 | 1.90 Mn |
| Jun 30, 2025 | 1.90 Mn |
| Mar 31, 2025 | -3.61 Mn |
| Mar 31, 2025 | -3.61 Mn |
| Dec 31, 2024 | 1.48 Mn |
| Dec 31, 2024 | 1.48 Mn |
| Sep 30, 2024 | 948,000.00 |
| Sep 30, 2024 | 948,000.00 |
| Jun 30, 2024 | 1.09 Mn |
| Jun 30, 2024 | 1.09 Mn |
| Mar 31, 2024 | -1.11 Mn |
| Mar 31, 2024 | -1.11 Mn |
| Dec 31, 2023 | -540,000.00 |
| Dec 31, 2023 | -540,000.00 |